The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation

Journal of Steroid Biochemistry and Molecular Biology

Volumn 85, Issue 2-5, 2003, Pages 235-245

  Barbier, Olivier ^a   Bélanger, Alain ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Cynomolgus monkey; Metabolites; Steroidogenesis

Indexed keywords

ALDOSTERONE; ANDROGEN; ANDROSTANE 3ALPHA DIOL GLUCURONIDE; ANDROSTERONE GLUCURONIDE; ESTROGEN DERIVATIVE; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; ISOENZYME; STEROID; UNCLASSIFIED DRUG;

CELL TYPE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONJUGATION; ENZYME ANALYSIS; ENZYME LOCALIZATION; EXON; GENE STRUCTURE; GENETIC TRANSCRIPTION; GLUCURONIDATION; HORMONE INHIBITION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRON; MACACA; MOLECULAR CLONING; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; STEROID METABOLISM; STEROIDOGENESIS; TISSUE DISTRIBUTION;

ANIMALIA; MACACA; MACACA FASCICULARIS; MAMMALIA;

EID: 0041887372     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00235-8     Document Type: Conference Paper

References (73)

1. G.J. Dutton, Glucuronidation of Drugs and Other Compounds, CRC Press, Boca Raton, FL, 1980.
2. Evans W.E., Relling M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 286(5439):1999;487-491.
3. Hum D.W., Bélanger A., Lévesque É., Barbier O., Beaulieu M., Albert C., Vallée M., Guillemette C., Tchernoff A., Turgeon D., Dubois S. Characterization of UDP-glucuronosyltransferases active on steroid hormones. J. Steroid Biochem. Mol. Biol. 69:1999;413-423.
4. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Bélanger A., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Chowdhury J.R., Ritter J.K., Schachter H., Tephly T.R., Tipton K.F., Nebert D.W. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 7(4):1997;255-269.
5. Owens I.S., Ritter J.K. Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation. Prog. Nucleic Acid. Res. Mol. Biol. 51:1995;305-338.
6. Owens I.S., Ritter J.K., Yeatman M.T., Chen F. The novel UGT1 gene complex links bilirubin, xenobiotics, and therapeutic drug metabolism by encoding UDP-glucuronosyltransferase isozymes with a common carboxyl terminus. J. Pharmacokinet. Biopharm. 24(5):1996;491-508.
7. Owens I.S., Ritter J.K. The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes. Pharmacogenetics. 2(3):1992;93-108.
8. Ritter J.K., Yeatman M.T., Ferreira P., Owens I.S. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J. Clin. Invest. 90(1):1992;150-155.
9. Strassburg C.P., Manns M.P., Tukey R.H. Expression of the UDP-glucuronosyltransferase 1A locus in human colon: identification and characterization of the novel extrahepatic UGT1A8. J. Biol. Chem. 273(15):1998;8719-8726.
10. King C.D., Green M.D., Rios G.R., Coffman B.L., Owens I.S., Bishop W.P., Tephly T.R. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch. Biochem. Biophys. 332(1):1996;92-100.
11. Senafi S.B., Clarke D.J., Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem. J. 303(Pt 1):1994;233-240.
12. Ebner T., Burchell B. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab. Dispos. 21(1):1993;50-55.
13. Heydel J., Leclerc S., Bernard P., Pelczar H., Gradinaru D., Magdalou J., Minn A., Artur Y., Goudonnet H. Rat olfactory bulb and epithelium UDP-glucuronosyltransferase 2A1 (UGT2A1) expression: in situ mRNA localization and quantitative analysis. Brain. Res. Mol. Brain Res. 90(1):2001;83-92.
14. Lazard D., Zupko K., Poria Y., Nef P., Lazarovits J., Horn S., Khen M., Lancet D. Odorant signal termination by olfactory UDP glucuronosyl transferase. Nature. 349(6312):1991;790-793.
15. Leclerc S., Heydel J.M., Amosse V., Gradinaru D., Cattarelli M., Artur Y., Goudonnet H., Magdalou J., Netter P., Pelczar H., Minn A. Glucuronidation of odorant molecules in the rat olfactory system: activity, expression and age-linked modifications of UDP-glucuronosyltransferase isoforms, UGT1A6 and UGT2A1, and relation to mitral cell activity. Brain Res. Mol. Brain Res. 107(2):2002;201-213.
16. Beaulieu M., Lévesque É., Hum D.W., Bélanger A. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J. Biol. Chem. 271(37):1996;22855-22862.
17. Coffman B.L., King C.D., Rios G.R., Tephly T.R. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y (268) and UGT2B7H (268). Drug Metab. Dispos. 26(1):1998;73-77.
18. Jin C.J., Miners J.O., Lillywhite K.J., Mackenzie P.I. cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem. Biophys. Res. Commun. 194(1):1993;496-503.
19. Lévesque É., Beaulieu M., Green M.D., Tephly T.R., Bélanger A., Hum D.W. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 7:1997;317-325.
20. Lévesque É., Beaulieu M., Hum D.W., Bélanger A. Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 9(2):1999;207-216.
21. Lévesque É., Turgeon D., Carrier J.S., Montminy V., Beaulieu M., Bélanger A. Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry. 40(13):2001;3869-3881.
22. Beaulieu M., Lévesque É., Hum D.W., Bélanger A. Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem. Biophys. Res. Commun. 248(1):1998;44-50.
23. Turgeon D., Carrier J.S., Lévesque É., Beatty B.G., Bélanger A., Hum D.W. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J. Mol. Biol. 295(3):2000;489-504.
24. Monaghan G., Burchell B., Boxer M. Structure of the human UGT2B4 gene encoding a bile acid UDP-glucuronosyltransferase. Mamm. Genome. 8(9):1997;692-694.
25. Carrier J.S., Turgeon D., Journault K., Hum D.W., Bélanger A. Isolation and characterization of the human UGT2B7 gene. Biochem. Biophys. Res. Commun. 272(2):2000;616-621.
26. Beaulieu M., Lévesque É., Tchernof A., Beatty B.G., Bélanger A., Hum D.W. Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. DNA Cell Biol. 16(10):1997;1143-1154.
27. D. Turgeon, S. Chouinard, P. Bélanger, S. Picard, J.F. Labbe, P. Borgeat, A. Bélanger, Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases, J. Lipid. Res. 44 (6) (2003) 1182-1191.
28. Pillot T., Ouzzine M., Fournel-Gigleux S., Lafaurie C., Radominska A., Burchell B., Siest G., Magdalou J. Glucuronidation of hydrodeoxycholic acid in human liver: evidence for a selective role of UDP-glucuronosyltransferase 2B4. J. Biol. Chem. 268(34):1993;25636-25642.
29. Labrie F., Bélanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 82(8):1997;2403-2409.
30. Brochu M., Bélanger A., Tremblay R.R. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women. Fertil. Steril. 48(6):1987;948-953.
31. Chen F., Ritter J.K., Wang M.G., McBride O.W., Lubet R.A., Owens I.S. Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochemistry. 32(40):1993;10648-10657.
32. Turgeon D., Carrier J., Lévesque É., Hum D.W., Bélanger A. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology. 142(2):2001;778-787.
33. C. Girard, O. Barbier, G. Veilleux, M. El Alfy, A. Bélanger, Human UDP-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites, Endocrinology, in press.
34. Gall W.E., Zawada G., Mojarrabi B., Tephly T.R., Green M.D., Coffman B.L., Mackenzie P.I., Radominska-Pandya A. Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J. Steroid Biochem. Mol. Biol. 70(1-3):1999;101-108.
35. Lavigne J.A., Helzlsouer K.J., Huang H.Y., Strickland P.T., Bell D.A., Selmin O., Watson M.A., Hoffman S., Comstock G.W., Yager J.D. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 57(24):1997;5493-5497.
36. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 19(1):1998;1-27.
37. Bélanger A., Caron S., Labrie F., Naldoni C., Dogliotti L., Angeli A. Levels of 18 non-conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type. Eur. J. Cancer. 26(3):1990;277-281.
38. Bélanger A., Couture J., Caron S., Roy R. Determination of nonconjugated and conjugated steroid levels in plasma and prostate after separation on C-18 columns. Ann. N.Y. Acad. Sci. 595:1990;251-259.
39. Prévost J., Brochu M., Bélanger A., Lambert R. Conjugated and unconjugated C-21, C-19 and C-18 steroid concentrations in human follicular fluid from hyperstimulated follicles. Gynecol. Endocrinol. 1(4):1987;331-338.
40. Chen W., Thiboutot D., Zouboulis C.C. Cutaneous androgen metabolism: basic research and clinical perspectives. J. Invest. Dermatol. 119(5):2002;992-1007.
41. Vallée M., Albert C., Beaudry G., Hum D.W., Bélanger A. Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens. J. Steroid Biochem. Mol. Biol. 77(4-5):2001;239-249.
42. Albert C., Vallée M., Beaudry G., Bélanger A., Hum D.W. The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes. Endocrinology. 140(7):1999;3292-3302.
43. Prakash C., Cui D. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Drug Metab. Dispos. 25(12):1997;1395-1406.
44. Moran F.M., Tarara R., Chen J., Santos S., Cheney A., Overstreet J.W., Lasley B.L. Effect of dioxin on ovarian function in the cynomolgus macaque (M. fascicularis). Reprod. Toxicol. 15(4):2001;377-383.
45. Kurebayashi H., Harada R., Stewart R.K., Numata H., Ohno Y. Disposition of a low dose of bisphenol a in male and female cynomolgus monkeys. Toxicol. Sci. 68(1):2002;32-42.
46. Dalvie D.K., O'Donnell J.P. Metabolism of CP-195,543, a leukotriene B4 receptor antagonist, in the Long-Evans rat and cynomolgus monkey. Xenobiotica. 29(11):1999;1123-1140.
47. Leblanc M., Labrie C., Bélanger A., Candas B., Labrie F. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey. J. Steroid Biochem. Mol. Biol. 81(2):2002;159-164.
48. Albert C., Barbier O., Vallée M., Beaudry G., Bélanger A., Hum D.W. Distribution of UDP-glucuronosyltransferase (UGT) expression and activity in the cynomolgus monkey tissues: evidence for a differential expression of steroid conjugating UGT enzymes in steroid target tissues. Endocrinology. 141(7):2000;1472-1480.
49. Strassburg C.P., Nguyen N., Manns M.P., Tukey R.H. UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology. 116(1):1999;149-160.
50. Strassburg C.P., Strassburg A., Nguyen N., Li Q., Manns M.P., Tukey R.H. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem. J. 338(Pt 2):1999;489-498.
51. Tukey R.H., Strassburg C.P. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol. Pharmacol. 59(3):2001;405-414.
52. Barbier O., Bélanger A., Hum D.W. Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid conjugating protein. Biochem. J. 337:1999;567-574.
53. Barbier O., Lévesque É., Bélanger A., Hum D.W. UGT2B23, a novel UDP-glucuronosyltransferase enzyme expressed in steroid target tissues that conjugates androgen and estrogen metabolites. Endocrinology. 140(12):1999;5538-5548.
54. Beaulieu M., Lévesque E., Barbier O., Turgeon D., Bélanger G., Hum D.W., Bélanger A. Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens. J. Mol. Biol. 275(5):1998;785-794.
55. Bélanger G., Beaulieu M., Lévesque E., Hum D.W., Bélanger A. Expression and characterization of a novel UDP-glucuronosyltransferase, UGT2B9, from cynomolgus monkey. DNA Cell Biol. 16(10):1997;1195-1205.
56. Bélanger G., Barbier O., Hum D.W., Bélanger A. Molecular cloning, expression and characterization of a monkey steroid UDP-glucuronosyltransferase, UGT2B19, that conjugates testosterone. Eur. J. Biochem. 260(3):1999;701-708.
57. Girard C., Barbier O., Turgeon D., Bélanger A. Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones. Biochem. J. 365(Pt 1):2002;213-222.
58. Barbier O., Girard C., Breton R., Bélanger A., Hum D.W. N-Glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltranferase enzymes. Biochemistry. 39(38):2000;11540-11552.
59. Mackenzie P.I. The effect of N-linked glycosylation on the substrate preferences of UDP glucuronosyltransferases. Biochem. Biophys. Res. Commun. 166(3):1990;1293-1299.
60. Barbier O., El Alfy M., Lapointe H., Bélanger A., Hum D.W. Cellular localization of UDP-glucuronosyltransferase 2B (UGT2B) enzymes in human prostate epithelium by in situ hybridization and immunohistochemistry. J. Clin. Endocrinol. Metab. 85(12):2000;4819-4826.
61. Emi Y., Ikushiro S., Iyanagi T. Drug-responsive and tissue-specific alternative expression of multiple first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene complex. J. Biochem. (Tokyo). 117(2):1995;392-399.
62. Kong A.N., Ma M., Tao D., Yang L. Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p). Pharm. Res. 10(3):1993;461-465.
63. Dean B., Chang S., Stevens J., Thomas P.E., King C. Isolation and characterization of a UDP-glucuronosyltransferase (UGT1A01) cloned from female rhesus monkey. Arch. Biochem. Biophys. 402(2):2002;289-295.
64. Barbier O., Girard C., Berger L., El Alfy M., Bélanger A., Hum D.W. The androgen conjugating UDP-glucuronosyltransferase 2B (UGT2B) enzymes are differentially expressed temporally and spatially in the monkey follicle throughout the menstrual cycle. Endocrinology. 142(6):2001;2499-2507.
65. Hillier S.G., Whitelaw P.F., Smyth C.D. Follicular oestrogen synthesis: the two-cell, two-gonadotrophin model revisited. Mol. Cell. Endocrinol. 100(1-2):1994;51-54.
66. Gomez-Sanchez C.E., Holland O.B. Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients. J. Clin. Endocrinol. Metab. 52(2):1981;214-219.
67. Bachmann S., Bostanjoglo M., Schmitt R., Ellison D.H. Sodium transport-related proteins in the mammalian distal nephron: distribution, ontogeny and functional aspects. Anat. Embryol. 200(5):1999;447-468.
68. Lohr J.W., Willsky G.R., Acara M.A. Renal drug metabolism. Pharmacol. Rev. 50(1):1998;107-141.
69. Guillemette C., Lévesque É., Beaulieu M., Turgeon D., Hum D.W., Bélanger A. Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology. 138(7):1997;2998-3005.
70. Guillemette C., Hum D.W., Bélanger A. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line. Endocrinology. 137(7):1996;2872-2879.
71. O. Barbier, I. Pineda Torra, A. Sirvent, T. Claudel, C. Blanquart, D. Duran-Sandoval, F. Kuipers, V. Kosykh, J.C. Fruchart, B. Staels, FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity, Gastroenterology 124 (7) (2003) 1926-1940.
72. O. Barbier, L. Villeneuve, V. Bocher, C. Fontaine, I. Pineda Torra, C. Duhem, V. Kosykh, J.C. Fruchart, C. Guillemette, B. Staels, The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene, J. Biol. Chem. 278 (16) (2003) 13975-13983.
73. Lin J.H. Complexities of glucuronidation affecting in vitro in vivo extrapolation. Curr. Drug Metab. 3(6):2002;623-646.